Evaluation of the efficacy of fresh bamboo juice in a population with borderline elevated lipids - a prospective, randomized, parallel, blank-controlled trial pilot study

Early Phase 1

• Conditions: Marginal elevation of blood lipids

• Registration Number: ITMCTR2023000045
• Lead Sponsor: Affiliated Hospital of Jiangxi University of Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 16 October 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

(1) BMI=24 kg/m2;

(2) In line with Western medicine borderline hyperlipidemia diagnosis;

(3) Age =18 years old, male or female;

(4) Sign informed consent.

Exclusion Criteria

(1) Combined with serious heart, brain and hematopoietic system and other primary diseases, combined with serious liver and kidney damage, there are malignant tumors;

(2) in preparation for pregnancy, pregnancy or lactation period;

(3) Combined with a major mental illness, unable to cooperate or unwilling to cooperate;

(4) known allergy to the drug ingredient;

(5) People who have taken weight-loss or lipid-regulating drugs in the past 3 months, affecting the judgment of the results;

(6) Weak spleen and stomach, easy loose stool diarrhea, or accompanied by intestinal diseases;

(7) Participants in other clinical trials in the past 3 months.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
tetrapolipidemia;

Secondary Outcome Measures

Name	Time	Method
Serum metabolomics;IL-6;TNF-a;Physical improvement;MCP-1;weight;NF-?B;